Clinical trials
Leukemia, Lymphocytic, Chronic, B-Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 6 |
| 2015 | 1 |
| 2016 | 9 |
| 2017 | 8 |
| 2018 | 3 |
| 2019 | 8 |
| 2020 | 8 |
| 2021 | 16 |
| 2022 | 11 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 12 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
| Recruiting | 27 |
| Active, not recruiting | 21 |
| Completed | 13 |
| Not yet recruiting | 4 |
| Terminated | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeOne Medicines | 9 |
| The First Affiliated Hospital with Nanjing Medical University | 7 |
| BeiGene | 6 |
| Institute of Hematology & Blood Diseases Hospital, China | 5 |
| AstraZeneca | 4 |
| Chinese PLA General Hospital | 4 |
| Janssen Research & Development, LLC | 4 |
| Loxo Oncology, Inc. | 4 |
| Ascentage Pharma Group Inc. | 3 |
| Dizal Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 108 |
| Lymphoma, Mantle-Cell | 27 |
| Lymphoma, Follicular | 21 |
| Lymphoma, Large B-Cell, Diffuse | 21 |
| Lymphoma, B-Cell | 19 |
| Lymphoma, Non-Hodgkin | 17 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 |
| Lymphoma | 11 |
| Hematologic Neoplasms | 10 |
| Recurrence | 10 |
Trials
Showing 51 to 75 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.